Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Detalles Bibliográficos
Autores principales: Liao, Xiaozhong, Gao, Ying, Liu, Jiahui, Tao, Lanting, Wang, Dongmei, Xie, Dan, Mo, Suilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057108/
https://www.ncbi.nlm.nih.gov/pubmed/33905466
http://dx.doi.org/10.3389/fonc.2021.670798
_version_ 1783680774868828160
author Liao, Xiaozhong
Gao, Ying
Liu, Jiahui
Tao, Lanting
Wang, Dongmei
Xie, Dan
Mo, Suilin
author_facet Liao, Xiaozhong
Gao, Ying
Liu, Jiahui
Tao, Lanting
Wang, Dongmei
Xie, Dan
Mo, Suilin
author_sort Liao, Xiaozhong
collection PubMed
description
format Online
Article
Text
id pubmed-8057108
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80571082021-04-21 Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway Liao, Xiaozhong Gao, Ying Liu, Jiahui Tao, Lanting Wang, Dongmei Xie, Dan Mo, Suilin Front Oncol Oncology Frontiers Media S.A. 2021-04-06 /pmc/articles/PMC8057108/ /pubmed/33905466 http://dx.doi.org/10.3389/fonc.2021.670798 Text en Copyright © 2021 Liao, Gao, Liu, Tao, Wang, Xie and Mo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liao, Xiaozhong
Gao, Ying
Liu, Jiahui
Tao, Lanting
Wang, Dongmei
Xie, Dan
Mo, Suilin
Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
title Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
title_full Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
title_fullStr Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
title_full_unstemmed Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
title_short Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
title_sort corrigendum: combination of tanshinone iia and cisplatin inhibits esophageal cancer by downregulating nf-κb/cox-2/vegf pathway
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057108/
https://www.ncbi.nlm.nih.gov/pubmed/33905466
http://dx.doi.org/10.3389/fonc.2021.670798
work_keys_str_mv AT liaoxiaozhong corrigendumcombinationoftanshinoneiiaandcisplatininhibitsesophagealcancerbydownregulatingnfkbcox2vegfpathway
AT gaoying corrigendumcombinationoftanshinoneiiaandcisplatininhibitsesophagealcancerbydownregulatingnfkbcox2vegfpathway
AT liujiahui corrigendumcombinationoftanshinoneiiaandcisplatininhibitsesophagealcancerbydownregulatingnfkbcox2vegfpathway
AT taolanting corrigendumcombinationoftanshinoneiiaandcisplatininhibitsesophagealcancerbydownregulatingnfkbcox2vegfpathway
AT wangdongmei corrigendumcombinationoftanshinoneiiaandcisplatininhibitsesophagealcancerbydownregulatingnfkbcox2vegfpathway
AT xiedan corrigendumcombinationoftanshinoneiiaandcisplatininhibitsesophagealcancerbydownregulatingnfkbcox2vegfpathway
AT mosuilin corrigendumcombinationoftanshinoneiiaandcisplatininhibitsesophagealcancerbydownregulatingnfkbcox2vegfpathway

Ejemplares similares